We have two production facilities of our own, with a total of 7.500 m2, devoted exclusively to manufacturing of oral solid products such as tablets, hard capsules and non-sterile powders to treat oncological, autoimmune, pneumological, nephrological and neurological diseases.
The installed capacity is over 105 million dosage units per year with 3 production shifts, satisfying the national and international demand.
View our products
Production facilities include technical offices, an industrial manufacturing plant for solid dosage forms, warehouses, research and development, a pilot plant, a quality control and quality assurance lab.
The productive process is performed with a quality system that ensures, by controlling different manufacturing stages, the required quality standards both nationally and internationally.
Our processes follow a Quality Management System setting under global cGMP regulations. In addition, storage and control measures comply with the National Dug Traceability System (Sistema Nacional de Trazabilidad de Medicamentos).
What is more, we have a pilot plant equipped with a team of professional pharmacists specialized in developing and studying new formulations. This plant is completely apart from the production area and it was designed following the same standards as the manufacturing area. It allows us to design, manufacture and study new products, improve existing formulations, refine processes to render them more efficient and transfer products for final processing.